Syngene is proud to sponsor the 7th edition of Women in Biopharma 2025, a vibrant and forward-looking platform where women leaders, innovators, and disruptors are shaping the future of the biopharma industry.
This year’s forum brings together voices that champion resilience, scientific excellence, and inclusive leadership. It’s more than an event — it’s a movement where every voice matters.
Featured Session: “In the Lab with CSOs”
Take a peek at Dr. Jayashree Aiyar, Chief Scientific Officer at Syngene, as she shares her personal journey in science and leadership. In this engaging session, Dr. Aiyar will explore the evolving role of women in biopharma and connect with fellow industry leaders on the challenges and triumphs of leading in a dynamic scientific landscape.
Key Takeaways from the Webinar
- Hear from top women leaders in STEM
- Network with peers and mentors across the industry
- Discover new perspectives on innovation and inclusion
- Be part of a community driving change in biopharma
Speaker Bio
Harish Kaushik Kotakonda, Ph.D.
Dr. Harish Kotakonda is a clinical pharmacologist with over 18 years of experience in DMPK and regulatory strategy across multiple therapeutic areas. He has contributed to 10 IND-stage and 5 approved NDA programs and has expertise in PBPK modelling, pharmacometrics, and clinical operations. He is the co-inventor of five patents filed in international and national jurisdictions.
Vishwottam Kandikere Ph.D.
Dr. Vishwottam Kandikere is a global clinical pharmacokineticist with 25 years of experience. He has contributed to 13 NCEs, holds 11 US patents, and has authored over 90 publications. His work spans therapeutic areas such as neuroscience, oncology, and metabolic disorders. He has successfully led the discovery and optimization of 13 NCEs from bench to early clinical trials. Dr. Kandikere holds a Ph.D. in Pharmaceutical Analysis from Jawaharlal Nehru Technological University, Hyderabad.
Rambabu Pattem
Mr. Rambabu Pattem brings over 23 years of experience in DMPK, with deep expertise in biotransformation, LCMS-based bioanalysis, and early-phase clinical studies. He has worked extensively on small molecules, peptides, and biologics across multiple CROs and discovery platforms. He has published five research articles in peer-reviewed journals. Rambabu completed his M. Pharmacy from Andhra University, Visakhapatnam.
